Completed

Study Description:

An Extension Trial Comparing Paroxetine and Placebo in the Long Term Treatment of Generalized Social Phobia

GSK Study ID:

29060/470


Has Results Document Available
ClinicalTrials.gov Identifier:

Not Available


EudraCT Number:

Not Available


Study Overview

Medical Conditions

Social Anxiety

Product

paroxetine

Collaborators

N/A


Date

August 1995 to December 1996

Type

N/A

Phase

3


Gender

N/A

Age

N/A

Accepts Healthy Volunteers

N/A


Study Documents


Locations

  • Central Contact :

    Not available

  • Central Contact Phone:

    Not Available

  • Central Contact Email:

    Not Available


Study Design

  • Primary Purpose: Not Available
  • Allocation: Not Available
  • Study Design: Not Available
  • Study Classification: Not Available
  • Masking: Not Available
  • Masked Subject: Not Available
  • Masked Caregiver: Not Available
  • Masked Investigator: Not Available
  • Masked Assessor: Not Available
Inclusion / Exclusion Criteria: Click to view inclusion/exclusion criteria:
Enrollment:

Clinical Publications:

  • Kumar R et al. Response to paroxetine is maintained during continued treatment in patients with social anxiety disorder. European Neuropsychopharmacology 9(S5): S312 (poster presentation)
  • Response to paroxetine is maintained during continued treatment in patients with social anxiety disorder. Kumar, R. , Pitts, C. , and Carpenter, D. 12th European College of Neuropsychopharmacology Congress (ECNP) 9/21/1999 London; UK